|
Product Details:
|
| Cas: | 247062-33-5 | MW: | 3960.5896 |
|---|---|---|---|
| Origin: | China | Appearance: | Powder |
| MF: | C174H300N56O49 | Storage: | 2-8°C |
| Shelf Life: | 2 Years | ||
| High Light: | Pharmaceutical Raw Powder CAS 247062-33-5,Increase Bone Mass Abaloparatide,99% Abaloparatide Pharmaceutical Raw Powder |
||
Increase Bone Mass Abaloparatide Pharmaceutical Raw Powder CAS 247062-33-5
| Product Name | Etelcalcetide |
| CAS | 1262780-97-1 |
| Molecular Formula | C38H73N21O10S2 |
| Assay | Above 99% |
| Test | HPLC |
| Certificate | ISO 9001 |
| Storage Temperature | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
Abaloparatide is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent. In 2017, it was approved to treat postmenopausal osteoporosis in the United States.
Application:
-Treatment of postmenopausal women with osteoporosis at high risk for fracture
-Increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture
-Treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture
Contact Person: Angie Zhang
Tel: +8613627115097
